Table 1.
Roles of GRKs in different cancer types
Cancer | GRK isoform | Change | Functional effect | Reference |
---|---|---|---|---|
Glioblastoma multiforme | GRK3 | Down | Increased growth of two different GBM cell lines | [37] |
GRK5 | Up | Positively correlated with aggressiveness of glioma. Increased the proliferation rate of GSC | [38] | |
Medulloblastoma | GRK6 | Down | Enhanced cell migration and CXCL12-mediated phosphorylation of ERK | [39] |
Thyroid carcinoma | GRK2 | Up | Reduction in proliferation of two poorly differentiated thyroid cell lines | [41] |
GRK5 | Down | Defect in homologous desensitization of the TSH receptor | [40] | |
Breast cancer | GRK2 | Up | Maintenance of tumoral proliferation and survival through regulating HDAC6/Pin1 axis | [42] |
GRK3 | Down | Increase of CXCR4-mediated invasion and metastasis of breast cancer cell | [47] | |
GRK4 | Up | Enhanced cell proliferation by activation of ERK and JNK through β-arrestin | [48] | |
Ovarian neoplasm | GRK2, GRK4 γ/δ | Up | Elevated in granulosa cell tumors | [49] |
Prostate cancer | GRK2 | Down | Trigger androgen-independent tumor growth | [51] |
GRK3 | Up | Increased angiogenesis, prostate tumor growth and metastasis | [52, 53] | |
GRK5 | Up | Increased proliferation, invasion, and metastasis of prostate cancer | [17, 54, 55] | |
Colorectal cancer | GRK5 | Down | Increased proliferation regulated by TIG1 | [57] |
Hepatocellular carcinoma | GRK2 | Down | Increased cell proliferation, migration and invasion | [58–61] |
Pancreatic cancer | GRK2 | Up | Accelerated cell growth. Predictive for poor overall survival of pancreatic cancer | [62, 63] |
Lung cancer | GRK6 | Down | Promoted tumor angiogenesis by upregulating MMP-2, MMP-9 release. Decreased survival | [64, 65] |
Oral squamous cell carcinoma | GRK3 | Up | Tumor malignancy and invasion | [67] |
Multiple myeloma | GRK6 | Up | Increased survival by enhanced phosphorylation of STAT3 | [68] |
Kaposi’s sarcoma | GRK2 | Down | Enhanced migration and invasion of endothelial cells via activation of CXCR2/Akt | [69] |
Osteosarcoma | GRK5 | Up | Decreased apoptosis by phosphorylating p53 and promoting its degradation | [71] |